TY - JOUR T1 - Postnatal contraception discontinuation: different methods, same problem JF - BMJ Sexual & Reproductive Health JO - BMJ Sex Reprod Health SP - 67 LP - 68 DO - 10.1136/bmjsrh-2017-101846 VL - 44 IS - 1 AU - Mandisa Singata-Madliki AU - Nolusindiso Dekile-Yonto AU - G J Hofmeyr AU - Theresa A Lawrie Y1 - 2018/01/01 UR - http://jfprhc.bmj.com/content/44/1/67.abstract N2 - Following publication of our trial on the effects of postnatal depot medroxyprogesterone acetate (DMPA) compared with the copper intrauterine device (IUD) on postnatal depression in this journal in July 2016,1 we have sought to evaluate contraceptive discontinuation in our study sample. Postnatal contraception is promoted as part of the WHO strategy to reduce the unmet need for family planning in low- and middle-income countries (LMICs) and to reduce preventable maternal and child mortality.2 However, little is known about discontinuation rates associated with postnatal contraception use in these settings.From the trial, 75 of 242 participants were contactable two or more years after randomisation and 54 consented to a follow-up interview, which was conducted by a Masters student from the University of Fort Hare (NDY). Twenty-three women had received DMPA and 31 women an IUD. In the DMPA and IUD arms, respectively, 48% (11/23) and 42% … ER -